Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1579 results

Double victory for Novartis at Federal Circuit


The US Court of Appeals for the Federal Circuit has reversed one decision and affirmed another in two cases involving Novartis, with both judgments delivering victory to the Swiss pharmaceutical company.

GE Healthcare files patent lawsuit against Bio-Rad


American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Allele Biotech partners with to develop nanoantibodies


US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.

Boehringer in research collaboration with Domain Therapeutics

Canada, France, Germany04-12-2018

German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics.

GSK seeks to boost oncology repertoire with $5.1bn acquisition

EU, UK, US03-12-2018

GSK has agreed to buy US oncology company Tesaro for $5.1 billion, in a move designed to strengthen its anti-cancer offering.

AbbVie and Pfizer in Humira licensing deal


AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30.

Washington University wins $31.6m in patent licensing spat


The University of Wisconsin’s licensing arm has been ordered to pay Washington University $31.6 million in a fight over patent licensing relating to one of AbbVie’s kidney drugs.

Abbott taken to court over coronary stent patent


California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California.

FDA seeks revamp of medical devices approvals


The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.

Life sciences partners join Saul Ewing’s Boston office


Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.

Showing 1 to 10 of 1579 results